$11.310
+0.173 (+1.53%)At close
Vicore Pharma Holding AB Financial Performance
The stock has a price-to-book ratio of 0.316, indicating it is undervalued relative to its book value, but this is overshadowed by its negative earnings metrics.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.